All In MedTech

Device Trial Radar · NCT04645173

Comparison of Participants Who Received a CanGaroo® Envelope, TYRX™ Envelope, or no Envelope During CIED Implantation

A Multi-Center Study Evaluating Participants Who Received CanGaroo® Envelope, TYRX™ Envelope, or No Envelope During CIED Implantation

Last checked: Nov 19, 2026Latest source record: Jan 9, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

46

Actual

Start

Feb 2, 2021

Primary completion

Oct 31, 2023

Study completion Dec 31, 2023

Sponsor

Lead sponsor
Elutia Inc.Not on our public-company list
Sponsor type
Industry
First posted
Nov 27, 2020

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to gather information on participants returning at time of CIED change-out or revision who underwent a device implantation with either a CanGaroo® envelope, TYRX™ envelope, or no envelope.

Conditions

  • Cardiac Disease

Interventions

  • CIED envelopeDevice

    Evaluation of the difference in cohorts for soft tissue healing surrounding the CIED implant and clinical outcomes and complications.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Blinded Histologic Evaluation of Biopsies Taken from the Anterior and Posterior Capsule WallTime frame: Surgical Procedure Visit

Locations

11 sites in 1 country. Site status is shown where the registry gives one.

  • Valley Heart Rhythm Specialists

    Chandler, Arizona

  • Bay Pines VA

    Bay Pines, Florida

  • Baptist Medical Center

    Jacksonville, Florida

8 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.